Lantheus Holdings, Inc. (LNTH) Financials

LNTH Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 2.3 billion 1.1 billion
Dec. 31, 2025 2.2 billion 1.1 billion
Sept. 30, 2025 2.3 billion 1.2 billion
June 30, 2025 2.1 billion 949.3 million

LNTH Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 121.9 million ?
Dec. 31, 2025 81.4 million 17.5 million
Sept. 30, 2025 94.7 million 24.5 million
June 30, 2025 73.7 million 22.3 million

LNTH Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 118.4 million
Dec. 31, 2025 54.1 million
Sept. 30, 2025 27.8 million
June 30, 2025 78.8 million

LNTH Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 498.6 million - -
Dec. 31, 2025 359.1 million 617.4 million 51.3 million
Sept. 30, 2025 382.0 million 566.4 million 52.2 million
June 30, 2025 695.6 million 566.8 million 47.9 million

LNTH Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 65.8 million
Dec. 31, 2025 66.3 million
Sept. 30, 2025 67.7 million
June 30, 2025 70.3 million

LNTH Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3.2 million 39.4 million 110.2 million 52.7 million
Dec. 31, 2025 8.8 million 47.5 million 116.2 million 46.3 million
Sept. 30, 2025 10.6 million 48.0 million 130.7 million 48.8 million
June 30, 2025 13.4 million 45.5 million 107.6 million 41.0 million

LNTH Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 377.3 million 146.4 million
Dec. 31, 2025 406.8 million 165.9 million
Sept. 30, 2025 384.0 million 161.6 million
June 30, 2025 378.0 million 137.0 million

LNTH Revenue by Segment

Graph available only for paid members. Upgrade to see it.

LNTH

Price: $102.82

52 week price:
47.25
108.91

Payout Ratio Range:
-36.85%
-0.62%

Earnings Per Share: 4.19 USD

P/E Ratio: 22.45

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 24390

Ebitda: 17.5 million

Market Capitalization: 6.1 billion

Links: